期刊文献+

瘀毒病机与动脉粥样硬化易损斑块相关的理论思考 被引量:90

Theoretical Thinking on Relationship between Toxic-stasis Pathogenicity and Atherosclerotic Vulnerable Plaque
下载PDF
导出
摘要 不稳定斑块破裂是发生具有代表性的心血管血栓性疾病——急性冠脉综合征(acute coronary syndrome,ACS)的主要原因。考虑到现代医学对于易损斑块炎性反应及血栓形成的病因学认识与中医学"毒"、"瘀"之病因病机和临证特点的相似性,加之临床表征方面的毒瘀特点,讨论中医学以"瘀血"为ACS的主要病因病机的传统认识似应扩展为"瘀毒"致动脉粥样硬化(AS)易损斑块破裂从而发生ACS。认为符合循证医学的临床研究以证实相关疾病的临床表征并形成"瘀毒"病因病机的临床诊疗规范,对于易损斑块及其作为病理基础的ACS这一心血管血栓性疾病的防治将具有积极的意义。 Vulnerable plaque rupture is the main cause of acute coronary syndrome (ACS), a representative cardiovascular thrombotic disease. Considering that the Western medical pathogenetic recognition on vulnerable plaque inflammatory reaction and thrombus formation is similar to the etiopathogenesis and clinical characteristics of toxin and stasis as well as the clinical manifestation of toxic-stasis in TCM, the authors believe that it is necessary to expand the previous TCM thinking on taking blood stasis as the main etiopathogenesis for ACS to that ACS is caused by the toxic-stasis induced vulnerable plaque rupture. Therefore to make sense, depending evidence-based medical principle, the relationship between toxic-stasis and vulnerable plaque forming and rupturing, and to form the clinical norm for diagnosis and treatment of toxic-stasis should be helpful for the prevention and control of ACS.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第4期366-368,共3页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家重点基础研究发展计划(973计划)项目(No.2006CB504803) 国家中医药管理局科技项目基金课题(No.0405JP64)
关键词 瘀毒 病因病机 易损斑块 急性冠脉综合征 心血管血栓性疾病 stagnant toxin etiopathogenesis vulnerable plaque acute coronary syndrome cardiovascularthrombotic disease
  • 相关文献

参考文献8

  • 1Liuzzo G, Santamaria M, Biasucci LM, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 2007, 49 (2): 185-194.
  • 2Hung M J, Chemg WJ, Cheng CW, et al. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 2006 , 97 (10) : 1429-1434.
  • 3Madjid M, Willerson JT, Casscells SW. Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coil Cardiol 2006 ,47 ( 8 ) : 80-85.
  • 4陆付耳,李鸣真,叶望云.清热解毒治法研究的思路与方法[J].中国中西医结合杂志,2004,24(12):1124-1129. 被引量:54
  • 5Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curt Mol Med 2005 , 5 (3) : 309-322.
  • 6Yang J, Li XP, Zhao SP, et al. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome. Clin Chim Acta 2006;368 (1-2) : 183- 187.
  • 7惠汝太.炎症反应与动脉粥样硬化及急性冠状动脉综合征[J].中国循环杂志,2000,15(5):259-260. 被引量:50
  • 8张京春,陈可冀,郑广娟,张文高,史大卓,殷惠军,刘龙涛.解毒活血中药配伍对载脂蛋白E基因敲除小鼠主动脉NF-κB与MMP-9表达的调控作用[J].中国中西医结合杂志,2007,27(1):40-44. 被引量:34

二级参考文献12

  • 1王霞,凌世峰.虎杖药理作用研究进展[J].海军医学杂志,2004,25(2):179-181. 被引量:22
  • 2郭志凌,赵华同,郑信华.穿心莲提取液减轻心肌缺血-再灌注过程中钙超负荷的机制探讨[J].中国病理生理杂志,1994,10(6):591-594. 被引量:3
  • 3张京春,陈可冀,张文高,史大卓.不稳定斑块的中西医结合认识现状及研究思路[J].中国中西医结合杂志,2005,25(10):869-871. 被引量:52
  • 4Plump AS,Smith JD,Hayek T,et al.Severe hypercholesterolemia and atheroslerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.Cell 1992; 71(2):343-353.
  • 5Ross R.Atherosclerosis is an inflammatory disease.Am Heart 1999;138(5):419-420.
  • 6Molnaco C,Paleolog E.Nuclear factor kappaB:a potential therapeutic target in atherosclerosis and thrombosis.Cardiovasc Res 2004; 61(4):671-682.
  • 7Orr AW,Sanders JM,Bevard M,et al.The subendothelial extracellular matrix modulates NF-kappaB activation by flow:a potential role in atherosclerosis.J Cell Biol 2005; 169 (1):191-202.
  • 8Lopez-Franco O,Hernandez-Vargas P,Ortiz-Munoz G,et al.Parthenolide modulates the NF-kappa B-mediated inflammatory responses in experimental atherosclerosis.Arterioscler Thromb Vasc Biol 2006; 26(8):1864-1870.
  • 9Brand K,Page S,Rogler G,et al.Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.Clin Invest 1996; 97(7):1715-1722.
  • 10de Nooijer R,Verkleij CJ,Von der Thusen JH,et al.Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.Arterioscler Thromb Vasc Biol 2006;26(2):340-346.

共引文献135

同被引文献1326

引证文献90

二级引证文献611

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部